Trials / Completed
CompletedNCT02676336
A Randomized Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Safety, Tolerability and Potential Effects of the Dietary Supplement Violet™ Molecular Iodine (I2) on Breast Health in Women With Cyclic Breast Discomfort and Tenderness
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- BioPharmX, Inc. · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind, placebo controlled, multi-center study to evaluate the safety, tolerability and potential effects of dietary supplement Violet™ Iodine on breast health in women with cyclic breast discomfort and tenderness to eliminate the evaluation of effectiveness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Violet™ Molecular Iodine (I2) | |
| OTHER | Placebo |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2018-01-31
- Completion
- 2018-01-31
- First posted
- 2016-02-08
- Last updated
- 2018-07-10
Locations
2 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT02676336. Inclusion in this directory is not an endorsement.